{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:55:14Z","timestamp":1791654914988,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejps.2025.107183","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:44:37Z","timestamp":1750819477000},"page":"107183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Advancing continuous encapsulation and purification of mRNA vaccines and therapeutics"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-5528","authenticated-orcid":false,"given":"Ehsan","family":"Nourafkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0077-9299","authenticated-orcid":false,"given":"Mabrouka","family":"Maamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6598-8369","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Kis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107183_bib0001","doi-asserted-by":"crossref","unstructured":"Abd-Razak N.H., Pihlajam\u00e4ki A., Virtanen T., Chew Y.J., Bird M.R.J.F., Processing B., The influence of membrane charge and porosity upon fouling and cleaning during the ultrafiltration of orange juice, 126 (2021) 184\u2013194.","DOI":"10.1016\/j.fbp.2021.01.009"},{"key":"10.1016\/j.ejps.2025.107183_bib0002","unstructured":"Aimar P., Howell J., Turner M.J.C.E.R., design, Effects of concentration boundary layer development on the flux limitations in ultrafiltration, 67 (1989) 255\u2013261."},{"key":"10.1016\/j.ejps.2025.107183_bib0003","series-title":"The New Continuous and Controlled Approach to Nanoparticle Processing","author":"Antonio Costa","year":"2024"},{"key":"10.1016\/j.ejps.2025.107183_bib0004","series-title":"Continuous mRNA Manufacturing: Is It the Next Wave in Manufacturing Innovation?","author":"Arnum","year":"2024"},{"key":"10.1016\/j.ejps.2025.107183_bib0005","doi-asserted-by":"crossref","unstructured":"Besseling R., Damen M., Wijgergangs J., Hermes M., Wynia G., Gerich A.J.E.J.o.P.S., New unique PAT method and instrument for real-time inline size characterization of concentrated, flowing nanosuspensions, 133 (2019) 205\u2013213.","DOI":"10.1016\/j.ejps.2019.03.024"},{"key":"10.1016\/j.ejps.2025.107183_bib0006","first-page":"688","article-title":"Properties of microfiltration membranes: flux loss during constant pressure permeation of bovine serum albumin","volume":"38","author":"Bowen","year":"1991","journal-title":"Bioengineering"},{"key":"10.1016\/j.ejps.2025.107183_bib0007","doi-asserted-by":"crossref","unstructured":"Brader M.L., Williams S.J., Banks J.M., Hui W.H., Zhou Z.H., Jin L.J.B.j., Encapsulation state of messenger RNA inside lipid nanoparticles, 120 (2021) 2766\u20132770.","DOI":"10.1016\/j.bpj.2021.03.012"},{"key":"10.1016\/j.ejps.2025.107183_bib0008","doi-asserted-by":"crossref","unstructured":"Buetehorn S., Carstensen F., Wintgens T., Melin T., Volmering D., Vossenkaul K.J.D., Permeate flux decline in cross-flow microfiltration at constant pressure, 250 (2010) 985\u2013990.","DOI":"10.1016\/j.desal.2009.09.087"},{"key":"10.1016\/j.ejps.2025.107183_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303370","article-title":"Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejps.2025.107183_bib0010","doi-asserted-by":"crossref","unstructured":"Cheng M.H.Y., Leung J., Zhang Y., Strong C., Basha G., Momeni A., Chen Y., Jan E., Abdolahzadeh A., Wang X.J.A.M., Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency, 35 (2023b) 2303370.","DOI":"10.1002\/adma.202303370"},{"key":"10.1016\/j.ejps.2025.107183_bib0011","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.xphs.2023.11.023","article-title":"Factors affecting stability of RNA\u2013temperature, length, concentration, pH, and buffering species","volume":"113","author":"Chheda","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107183_bib0012","first-page":"962","article-title":"Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production","volume":"109","author":"Dizon-Maspat","year":"2012","journal-title":"Bioengineering"},{"key":"10.1016\/j.ejps.2025.107183_bib0013","doi-asserted-by":"crossref","unstructured":"Domokos A., Nagy B., Szilagyi B., Marosi G., Nagy Z.K.J.O.P.R., Development, integrated continuous pharmaceutical technologies\u2014A review, 25 (2021) 721\u2013739.","DOI":"10.1021\/acs.oprd.0c00504"},{"key":"10.1016\/j.ejps.2025.107183_bib0014","article-title":"First continuous mRNA manufacturing platform to be developed","author":"Eckford","year":"2023","journal-title":"Eur. Pharm. Rev."},{"key":"10.1016\/j.ejps.2025.107183_bib0015","doi-asserted-by":"crossref","unstructured":"Furukawa K., Judai K.J.T.J.o.C.P., Brownian motion probe for water-ethanol inhomogeneous mixtures, 147 (2017).","DOI":"10.1063\/1.5007813"},{"key":"10.1016\/j.ejps.2025.107183_bib0016","doi-asserted-by":"crossref","unstructured":"Gerstweiler L., Bi J., Middelberg A.P.J.C.E.S., Continuous downstream bioprocessing for intensified manufacture of biopharmaceuticals and antibodies, 231 (2021) 116272.","DOI":"10.1016\/j.ces.2020.116272"},{"key":"10.1016\/j.ejps.2025.107183_bib0017","unstructured":"GY S.J.A.C.E.R., Ethanol and membrane lipids, 185 (1985) 1\u20135."},{"key":"10.1016\/j.ejps.2025.107183_bib0018","doi-asserted-by":"crossref","unstructured":"Hardianto A., Muscifa Z.S., Widayat W., Yusuf M., Subroto T.J.M., The effect of ethanol on lipid nanoparticle stabilization from a molecular dynamics simulation perspective, 28 (2023) 4836.","DOI":"10.3390\/molecules28124836"},{"key":"10.1016\/j.ejps.2025.107183_bib0019","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/pr11061718","article-title":"Formulation of nucleic acids by encapsulation in lipid nanoparticles for continuous production of mRNA","volume":"11","author":"Hengelbrock","year":"2023","journal-title":"Processes"},{"key":"10.1016\/j.ejps.2025.107183_bib0020","volume":"10001","year":"2021"},{"key":"10.1016\/j.ejps.2025.107183_bib0021","unstructured":"I.H.T.J.C.S. Guideline, Impurities: guideline for residual solvents Q3C (R5), 4 (2005) 1\u201325."},{"key":"10.1016\/j.ejps.2025.107183_bib0022","series-title":"Analytical Procedures for Quality of mRNA Vaccines and Therapeutics","year":"2023"},{"key":"10.1016\/j.ejps.2025.107183_bib0023","doi-asserted-by":"crossref","unstructured":"Jones L.J., Yue S.T., Cheung C.Y., Singer V.L.J.A.B., RNA quantitation by fluorescence-based solution assay: riboGreen reagent characterization, 265 (1998) 368\u2013374.","DOI":"10.1006\/abio.1998.2914"},{"key":"10.1016\/j.ejps.2025.107183_bib0024","doi-asserted-by":"crossref","unstructured":"Kafetzis K.N., Papalamprou N., McNulty E., Thong K.X., Sato Y., Mironov A., Purohit A., Welsby P.J., Harashima H., Yu-Wai-Man C.J.A.H.M., The effect of Cryoprotectants and storage conditions on the transfection efficiency, stability, and safety of lipid-based nanoparticles for mRNA and DNA delivery, 12 (2023) 2203022.","DOI":"10.1002\/adhm.202203022"},{"key":"10.1016\/j.ejps.2025.107183_bib0025","doi-asserted-by":"crossref","unstructured":"Kauffman K.J., Dorkin J.R., Yang J.H., Heartlein M.W., DeRosa F., Mir F.F., Fenton O.S., Anderson D.G.J.N.L., Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs, 15 (2015) 7300\u20137306.","DOI":"10.1021\/acs.nanolett.5b02497"},{"key":"10.1016\/j.ejps.2025.107183_bib0026","doi-asserted-by":"crossref","unstructured":"Kim B., Hosn R.R., Remba T., Yun D., Li N., Abraham W., Melo M.B., Cortes M., Li B., Zhang Y.J.J.O.C.R., Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines, 353 (2023) 241\u2013253.","DOI":"10.1016\/j.jconrel.2022.11.022"},{"key":"10.1016\/j.ejps.2025.107183_bib0027","doi-asserted-by":"crossref","unstructured":"Kimura N., Maeki M., Sato Y., Ishida A., Tani H., Harashima H., Tokeshi M.J.A.A.M., Development of a microfluidic-based post-treatment process for size-controlled lipid nanoparticles and application to siRNA delivery, interfaces, 12 (2020) 34011\u201334020.","DOI":"10.1021\/acsami.0c05489"},{"key":"10.1016\/j.ejps.2025.107183_bib0028","doi-asserted-by":"crossref","unstructured":"Kimura N., Maeki M., Sato Y., Note Y., Ishida A., Tani H., Harashima H., Tokeshi M.J.A.O., Development of the iLiNP device: fine tuning the lipid nanoparticle size within 10 nm for drug delivery, 3 (2018) 5044\u20135051.","DOI":"10.1021\/acsomega.8b00341"},{"key":"10.1016\/j.ejps.2025.107183_bib0029","doi-asserted-by":"crossref","unstructured":"Kotou\u010dek J., Hubatka F., Ma\u0161ek J., Kulich P., Vel\u00ednsk\u00e1 K., Bezd\u011bkov\u00e1 J., Fojt\u00edkov\u00e1 M., Bartheldyov\u00e1 E., Tome\u010dkov\u00e1 A., Str\u00e1sk\u00e1 J.J.S.R., Preparation of nanoliposomes by microfluidic mixing in herring-bone channel and the role of membrane fluidity in liposomes formation, 10 (2020) 5595.","DOI":"10.1038\/s41598-020-62500-2"},{"key":"10.1016\/j.ejps.2025.107183_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/713609236","article-title":"Group II introns: structure and catalytic versatility of large natural ribozymes","volume":"38","author":"Lehmann","year":"2003","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejps.2025.107183_bib0031","doi-asserted-by":"crossref","unstructured":"Leung A.K., Tam Y.Y.C., Chen S., Hafez I.M., Cullis P.R.J.T.J.O.P.C.B., Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems, 119 (2015) 8698\u20138706.","DOI":"10.1021\/acs.jpcb.5b02891"},{"key":"10.1016\/j.ejps.2025.107183_bib0032","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1021\/ja990592p","article-title":"Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2 \u2018-hydroxyl group","volume":"121","author":"Li","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107183_bib0033","doi-asserted-by":"crossref","unstructured":"Ly H.H., Daniel S., Soriano S.K., Kis Z., Blakney A.K.J.M.P., Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach, 19 (2022) 1892\u20131905.","DOI":"10.1021\/acs.molpharmaceut.2c00032"},{"key":"10.1016\/j.ejps.2025.107183_bib0034","doi-asserted-by":"crossref","unstructured":"Malladi S., Coolbaugh M.J., Thomas C., Krishnan S., Varner C.T., Walther J., Brower K.P.J.J.O.M.S., Design of a process development workflow and control strategy for single-pass tangential flow filtration and implementation for integrated and continuous biomanufacturing, 677 (2023) 121633.","DOI":"10.1016\/j.memsci.2023.121633"},{"key":"10.1016\/j.ejps.2025.107183_bib0035","doi-asserted-by":"crossref","unstructured":"Marino K., Levison P.J.G.E., News B., Achieving process intensification with single-pass TFF: improving process economics and speed to market with cross-functional inline concentration, 37 (2017) 30\u201331.","DOI":"10.1089\/gen.37.15.14"},{"key":"10.1016\/j.ejps.2025.107183_bib0036","unstructured":"Maxmen A., The WHO's push for global mRNA vaccine access. Will the WHO hub realize its vision before the next global health crisis?, www.thinkglobalhealth.org., 2024."},{"key":"10.1016\/j.ejps.2025.107183_bib0037","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3762\/bjoc.14.68","article-title":"Phosphodiester models for cleavage of nucleic acids","volume":"14","author":"Mikkola","year":"2018","journal-title":"Beilstein. J. Org. Chem."},{"key":"10.1016\/j.ejps.2025.107183_bib0038","doi-asserted-by":"crossref","unstructured":"Miller D.J., Kasemset S., Paul D.R., Freeman B.D.J.J.O.M.S., Comparison of membrane fouling at constant flux and constant transmembrane pressure conditions, 454 (2014) 505\u2013515.","DOI":"10.1016\/j.memsci.2013.12.027"},{"key":"10.1016\/j.ejps.2025.107183_bib0039","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2025.107183_bib0040","series-title":"MIT Receives $82m from FDA For Continuous mRNA Manufacturing Platform","author":"Nelson","year":"2023"},{"key":"10.1016\/j.ejps.2025.107183_bib0041","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2025.107183_bib0042","doi-asserted-by":"crossref","unstructured":"Qu J., Nair A., Muir G.W., Loveday K.A., Yang Z., Nourafkan E., Welbourne E.N., Maamra M., Dickman M.J., Kis Z.J.M.T.N.A., Quality by design for mRNA platform purification based on continuous oligo-dT chromatography, 35 (2024).","DOI":"10.1016\/j.omtn.2024.102333"},{"key":"10.1016\/j.ejps.2025.107183_bib0043","doi-asserted-by":"crossref","unstructured":"Reinhart A.G., Osterwald A., Ringler P., Leiser Y., Lauer M.E., Martin R.E., Ullmer C., Schumacher F., Korn C., Keller M.J.M.P., Investigations into mRNA lipid nanoparticles shelf-life stability under nonfrozen conditions, 20 (2023) 6492\u20136503.","DOI":"10.1021\/acs.molpharmaceut.3c00956"},{"key":"10.1016\/j.ejps.2025.107183_bib0044","doi-asserted-by":"crossref","unstructured":"Schoenmaker L., Witzigmann D., Kulkarni J.A., Verbeke R., Kersten G., Jiskoot W., Crommelin D.J.J.I.J.O.P., mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability, 601 (2021) 120586.","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"10.1016\/j.ejps.2025.107183_bib0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2024.07.046","article-title":"A perspective on bleb and empty LNP structures","volume":"373","author":"Simonsen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107183_bib0046","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-023-00977-5","article-title":"mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications","volume":"30","author":"Wang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejps.2025.107183_bib0047","doi-asserted-by":"crossref","unstructured":"Weatherly C.A., Woods R.M., Armstrong D.W.J.J.O.A., f. chemistry, Rapid analysis of ethanol and water in commercial products using ionic liquid capillary gas chromatography with thermal conductivity detection and\/or barrier discharge ionization detection, 62 (2014) 1832\u20131838.","DOI":"10.1021\/jf4050167"},{"key":"10.1016\/j.ejps.2025.107183_bib0048","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acs.molpharmaceut.2c00010","article-title":"Current status and future perspectives on MRNA drug manufacturing","volume":"19","author":"Webb","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107183_bib0049","doi-asserted-by":"crossref","unstructured":"Webb C., Ip S., Bathula N.V., Popova P., Soriano S.K., Ly H.H., Eryilmaz B., Nguyen Huu V.A., Broadhead R., Rabel M.J.M.p., Current status and future perspectives on MRNA drug manufacturing, 19 (2022b) 1047\u20131058.","DOI":"10.1021\/acs.molpharmaceut.2c00010"},{"key":"10.1016\/j.ejps.2025.107183_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1250833","article-title":"Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development","volume":"11","author":"Welbourne","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejps.2025.107183_bib0051","doi-asserted-by":"crossref","unstructured":"Welbourne E.N., Loveday K.A., Nair A., Nourafkan E., Qu J., Cook K., Kis Z., Dickman M.J.J.F.I.M.B., Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development, 11 (2024b) 1250833.","DOI":"10.3389\/fmolb.2024.1250833"},{"key":"10.1016\/j.ejps.2025.107183_bib0052","doi-asserted-by":"crossref","unstructured":"Yan L.L., Zaher H.S.J.J.O.B.C., How do cells cope with RNA damage and its consequences?, 294 (2019) 15158\u201315171.","DOI":"10.1074\/jbc.REV119.006513"},{"key":"10.1016\/j.ejps.2025.107183_bib0053","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T10:13:40Z","timestamp":1757844820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"alternative-id":["S0928098725001824"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107183","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing continuous encapsulation and purification of mRNA vaccines and therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107183"}}